Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
435-455
Author(s):
M. Kivikko and L. Lehtonen
Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
489-509
Author(s):
Alain Grynberg
Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases
Journal:
Current Drug Targets
Volume:
6
Page:
21-29
Author(s):
A. Forte, M. Cipollaro, A. Cascino and U. Galderisi
Anticancer Drugs Targeting the Apoptotic Pathway
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
2
Page:
67-79
Author(s):
M. Tolomeo, N. Gebbia and D. Simoni
The Future of Angiotensin II Inhibition in Cardiovascular Medicine
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
15-30
Author(s):
Pascal Meier, Marc Maillard and Michel Burnier
Subject Index to Volume 4
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
103-109
Author(s):
Bentham Science Publishers
The Antagonists of Endothelin Receptors: Results and Perspectives
Journal:
Current Pharmaceutical Analysis
Volume:
1
Page:
93-108
Author(s):
Alessandro Cosenzi
Extracellular Matrix Remodeling in Hypertension
Journal:
Current Hypertension Reviews
Volume:
1
Page:
51-60
Author(s):
Hiroyuki Sasamura, Ryoko Shimizu-Hirota and Takao Saruta
Effect of the Antihypertensive Treatment on the Bone Mineral Density and Osteoporotic Fracture
Journal:
Current Hypertension Reviews
Volume:
1
Page:
61-66
Author(s):
Jose L. Perez-Castrillon, Isabel Justo, Alberto Sanz-Cantalapiedra, Carol Pueyo, Gonzalo Hernandez and Antonio Duenas
Novel Strategies for the Management of Acute Decompensated Heart Failure
Journal:
Current Cardiology Reviews
Volume:
1
Page:
1-5
Author(s):
W. H.Wilson Tang and Robert E. Hobbs